BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hyuk-Jin Cha |
| Publication date | June 10, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |